Scott Copeland
About Scott Copeland
Scott Copeland is Executive Vice President and Chief Operations Officer (COO) of BancFirst (BancFirst Corporation), age 60, and has been an executive officer since 1992 . His role centers on operations, including oversight of information systems, digital delivery, operational compliance/support, item processing, treasury services support, core banking systems facilities/operations, multiple system conversions/upgrades, and renewing the core processing contract . Company performance context during his recent tenure shows net income of $193.1M (2022), $212.5M (2023), and $216.4M (2024), with diluted EPS of $5.77, $6.34, and $6.44 respectively, and 5‑year TSR value of $208.74 vs. peer group $128.85 in 2024 .
Past Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| BancFirst (principal subsidiary) | Executive Vice President & COO | Executive officer since 1992 | Oversight of Information Systems, Digital Delivery, Operational Compliance/Support, Item Processing, Treasury Services Sales/Support; monitor budget vs. actual; oversee system conversions/upgrades; renew core processing contract |
External Roles
- No external public company directorships disclosed for Copeland in the executive officer section of the latest proxy filings reviewed .
Fixed Compensation
| Year | Base salary ($) | Non‑qualified deferred comp earnings ($) | All other compensation ($) | Notes |
|---|---|---|---|---|
| 2022 | 411,538 | 42,124 | 23,067 | “All other” includes retirement plan contributions and life insurance; company provides auto perquisites (as applicable) |
| 2023 | 450,000 | 46,080 | 25,257 | Survivor benefit agreement participants include Copeland; value included in “all other compensation” |
| 2024 | 475,000 | 50,364 | 27,421 | Survivor benefit agreement continues; no stock ownership guidelines for executives |
Performance Compensation
- Annual bonus framework and outcomes:
- 2022: Eligible up to 20% of base; awarded maximum — 20% cash and additional 5% deferred bonus (payable end of 2025) based on subjective assessment of objectives tied to operations and systems initiatives .
- 2023: Eligible up to 20% of base; awarded maximum — 20% cash and 5% deferred (payable end of 2026) on similar qualitative objectives .
- 2024: Eligible up to 25% of base; awarded maximum — 20% cash and 5% deferred (payable end of 2027) on operational execution objectives .
| Year | Target bonus (% of salary) | Actual payout (% of salary) | Cash payout ($) | Deferred bonus ($) | Performance metrics/assessment |
|---|---|---|---|---|---|
| 2022 | 20% | 25% (20% cash + 5% deferred) | ~82,308 (20% of $411,538) | 21,250 | Qualitative: org structure/systems, core systems ops, budget vs. actual, system conversions, core contract renewal; subjectively assessed as successful |
| 2023 | 20% | 25% (20% cash + 5% deferred) | 90,000 (20% of $450,000) | 22,500 | Similar qualitative objectives; assessed as successful |
| 2024 | 25% | 25% (20% cash + 5% deferred) | 95,000 (20% of $475,000) | 23,750 | Similar qualitative objectives; assessed as successful |
Note: The Summary Compensation Table shows “Performance‑based Incentive Pay” of $102,750 (2022), $112,500 (2023), and $118,750 (2024), which include the deferred bonus components .
Long‑term equity incentives
- Equity program transition: Legacy Stock Option Plan replaced by the 2023 RSU Plan (effective 6/1/2023). RSUs vest beginning two years after grant, at 20% per year for 5 years; awards recommended by Executive Committee and ratified by the Board; no stock ownership guidelines for directors or executives . No RSUs were granted to Copeland in 2024; the only 2024 NEO RSU grant was to the CFO (4,000 units on 3/29/2024, FV $352,120) .
| Grant type | Grant date | Quantity | Strike/Fair value | Vesting | Expiration |
|---|---|---|---|---|---|
| Nonqualified stock options | 6/17/2022 | 10,000 | $94.86 strike; Grant‑date FV $352,147 | 25% annually 6/17/2026–6/17/2029 | 6/17/2037 |
Multi‑year Compensation Mix (Summary)
| Year | Salary ($) | Performance‑based incentive pay ($) | Stock awards ($) | Option awards ($) | NQDC earnings ($) | All other ($) | Total ($) |
|---|---|---|---|---|---|---|---|
| 2022 | 411,538 | 102,750 | — | 352,147 | 42,124 | 23,067 | 931,626 |
| 2023 | 450,000 | 112,500 | — | — | 46,080 | 25,257 | 633,837 |
| 2024 | 475,000 | 118,750 | — | — | 50,364 | 27,421 | 671,535 |
Equity Ownership & Alignment
- Stock ownership guidelines: The company has no stock ownership guidelines for directors or executive officers .
- Beneficial ownership: Copeland’s reported beneficial holdings are in company retirement plans; no shares are flagged as pledged for Copeland in the beneficial ownership footnotes (pledging is noted for other individuals where applicable) .
| As‑of date | Beneficial ownership (shares) | Percent of class | Footnote |
|---|---|---|---|
| 3/31/2023 | 15,501 | <1% | Consists of shares held by Retirement Plans for Copeland |
| 3/28/2024 | 15,824 | <1% | Held by Retirement Plans |
| 3/31/2025 | 13,740 | <1% | Held by Retirement Plans |
- Outstanding equity at 12/31/2024:
- Options: 10,000 unexercisable at $94.86, vesting 25% per year 2026–2029; expiration 6/17/2037 .
- RSUs: none outstanding for Copeland .
| Instrument | Exercisable | Unexercisable | Strike | Vesting cadence | Expiration |
|---|---|---|---|---|---|
| Options (grant 6/17/2022) | — | 10,000 | $94.86 | 25%/yr from 6/17/2026–2029 | 6/17/2037 |
- Intrinsic value context (12/31/2024): BANF closing price $117.18; Copeland’s 10,000 options at $94.86 were in‑the‑money by $22.32 per share, implying ~$223k intrinsic value at that date (inputs: $117.18 and $94.86) .
Employment Terms
- Supplemental Executive Retirement Agreement (SERA, dated 11/15/2006): Present value of Copeland’s accumulated benefit was $368,143 (2022), $414,223 (2023), and $464,586 (2024) . If employed until age 65, he is entitled to $100,000 per year for 10 years; a lump‑sum (discounted present value) is payable upon separation following a change of control or if terminated without cause between ages 59–65; no benefits if he leaves before 59 (other than death) or is terminated for cause before 65; non‑compete/confidentiality violations forfeit benefits .
- Survivor Benefit Agreement: Company‑owned life insurance benefit; beneficiary receives specified death benefit if death occurs while employed; value included in “All Other Compensation.” Copeland is a participant (with Harlow and Schmidt) .
- Other severance/COC agreements: Except for the SERA described above, the company states no other agreements providing potential payments upon termination or change‑in‑control for named executive officers .
| SERA valuation snapshot | Years of credited service | PV of accumulated benefit ($) |
|---|---|---|
| 12/31/2022 | 30.4 | 368,143 |
| 12/31/2023 | 31.4 | 414,223 |
| 12/31/2024 | 32.4 | 464,586 |
Compensation Committee, Say‑on‑Pay, and Performance Linkage
- Compensation Committee (independent): F. Ford Drummond, Joseph Ford, and G. Rainey Williams, Jr. (Chair) .
- Say‑on‑pay support: ~95% approval in 2023; 99% in 2024 .
- Pay versus Performance indicators (Company level):
- 2024 TSR index $208.74 (vs. peer $128.85), net income $216.4M, diluted EPS $6.44 .
- 2023 TSR index $170.28 (peer $106.87), net income $212.5M, diluted EPS $6.34 .
- Most important measures used by committee: budgeted net income, classified assets to capital, internal audit ratings .
| Year | TSR (Value of $100) | Peer TSR | Net income ($000s) | Diluted EPS |
|---|---|---|---|---|
| 2024 | 208.74 | 128.85 | 216,354 | 6.44 |
| 2023 | 170.28 | 106.87 | 212,465 | 6.34 |
| 2022 | 151.45 | 110.67 | 193,100 | 5.77 |
Risk Indicators & Red Flags (as disclosed)
- Pledging/Hedging: Beneficial ownership footnotes identify pledging for other individuals where applicable; no pledging disclosure is noted for Copeland; company has no stock ownership guidelines for executives .
- Equity award practices: No option repricing in prior 12 months under the former option plan; options granted at market price; RSU plan implemented in 2023 .
- Related‑party transactions: Company outlines Regulation O policy and review; no Copeland‑specific related‑party items disclosed in the sections reviewed .
Investment Implications
- Alignment and selling pressure: Copeland holds no RSUs and only unexercisable options that begin vesting June 2026, reducing near‑term selling pressure from equity vestings; options are in‑the‑money at 12/31/2024 (intrinsic value context ~$223k), but not exercisable until vest tranches begin in 2026 . The company has no executive ownership guidelines, which reduces formal alignment requirements vs. peers .
- Pay for performance: Annual incentives for Copeland are capped at 25% of salary and determined through qualitative, subjective assessments of operational objectives; this provides line‑of‑sight but may weaken direct linkage to shareholder metrics vs. explicit financial targets, though company‑level pay‑versus‑performance disclosure ties compensation to net income/EPS and shows TSR outperformance vs. peers in 2023–2024 .
- Retention/COC economics: Copeland’s SERA provides $100,000 per year for 10 years at retirement age 65 and a lump‑sum upon qualifying termination/change‑of‑control, creating meaningful retention value (PV $464,586 at YE 2024) without additional severance multiples beyond the SERA framework . Survivor benefit agreements add ancillary retention value .
- Governance/Shareholder sentiment: High say‑on‑pay support (95% in 2023; 99% in 2024) suggests low compensation‑related shareholder friction; Compensation Committee is independent .
Overall: Limited equity overhang specific to Copeland near term (no RSUs; options vest 2026‑2029), strong qualitative operational focus for bonuses, and substantial SERA retention benefits; absence of ownership guidelines is a governance trade‑off investors should monitor alongside any future RSU participation and insider Form 4 activity .